Joseph Beaulieu, Corporate Controller at Epizyme, Inc. (EPZM), sold 687 shares at $1.37 ($941) on 2022-02-02, disclosed to the SEC on 2022-02-04.
Scheduled sale ($941) by Corporate Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EPZM | SELL | 2020-09-03 | $19K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $5K | — | Filing → |
| EPZM | SELL | 2020-03-26 | $3K | — | Filing → |